Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer

Given orally for 14 consecutive days (days 1-14) followed by a week of no capecitabine then another week of 14 consecutive days (days 21-28).

Given intravenously once weekly during weeks 1, 2, 4 and 5 on days 1, 8, 22 and 29

Given intravenously every two weeks during weeks 1, 3 and 5 on days 1, 15 and 29.

Once daily for 5 days (Monday through Friday) for a total of 28 treatments.